Parysa Oskouipour

Ms. Parysa Oskouipour


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
NSNicole Salisbury
Nicole Salisbury
IHIqbal Hossain
Iqbal Hossain
POParysa Oskouipour
Parysa Oskouipour
AHAudry Hong
Audry Hong
EEElan Ebeling
Elan Ebeling
EGEmily Grapa
Emily Grapa
Background: Microplanning is widely recognized as a critical tool for improving immunization coverage and equity and is considered a core component of routine immunization. However, there is limited evidence on how microplans are developed and implemented and the effectiveness of microplanning. As such, this study sought to review the existing evidence on implementation and institutionalization of microplanning; identify strategies to improve microplanning; and document evidence on new approaches to microplanning, including digitally enhanced and integrated microplanning. Methods: We employed a three-stage mixed-method approach. First, we conducted a literature review on microplanning for routine immunization. Second, we administered an online survey to gather insights into the factors that constrained and enabled microplanning in low-resource settings. Third, we conducted key informant interviews to better understand the barriers and enablers. Results: We found a paucity of published literature describing the drivers and effectiveness of microplanning and how to sustain it over time. Our review indicates that factors at both the development and implementation stages influence implementation and whether the process is sustained over time. These include the level of community engagement and health care worker ownership, access to data, the complexity of the microplanning tools, and the extent to which supervisors follow up on the plans. Conclusion: Our review indicates that microplanning is successful when health care workers and communities are engaged in the development process. While these findings highlight the benefits of a ‘bottom-up’ approach to microplanning, this may be more resource-intensive, and there remains a need for more research on the costs and benefits.

6 May 2024 in Oxford Open Digital Health
Verified
Journal Article
Open access
NKNami Kawakyu
Nami Kawakyu
AOAllison Osterman
Allison Osterman
JMJimi Michel
Jimi Michel
DMDominic Mutai
Dominic Mutai
EJEdith Jepleting
Edith Jepleting
JSJessica Catherine Shearer
Jessica Catherine Shearer
To achieve the Immunization Agenda 2030 vaccine equity vision of a world where everyone everywhere benefits from vaccines, it is essential to invest in immunization information systems that can support the identification, reach and monitoring of zero-dose and under-immunized children. The rapid nature of COVID-19 vaccine introduction led to the investment of new systems to collect, manage and use immunization data. While many digital health assessment tools exist, there is an absence of tools to support decision-makers to systematically assess the suitability of transferring an immunization information system from one health context to another. To address this gap, the COVID-19 to Routine Immunization Information System Transferability Assessment tool was developed, informed by literature review, expert consultation and usability testing. The tool is organized into five thematic areas: context, functionality, technology, users and resources. Each thematic area has questions about the COVID-19 immunization information system, the current and desired state of the routine immunization information system and the gaps between them. Suitability scores are then calculated to assess whether a COVID-19 immunization information system is suitable for routine immunization so governments can leverage these investments to strengthen routine immunization programs and the broader health information ecosystem. Abrégé Pour réaliser la vision du Programme pour la vaccination à l’horizon 2030 concernant l’équité vaccinale d’un monde où tout le monde, partout, bénéficie des vaccins, il est essentiel d’investir dans des systèmes d’information sur la vaccination capables d’appuyer l’identification, l’accès et le suivi des enfants zéro dose et insuffisamment vaccinés. La nature rapide de l’introduction du vaccin contre la COVID-19 a entraîné l’investissement dans de nouveaux systèmes de collecte, de gestion et d’utilisation des données sur la vaccination. Bien que de nombreux outils numériques d’évaluation de la santé existent, on ne dispose d’aucun outil pour aider les décideurs à évaluer systématiquement la pertinence du transfert d’un système d’information sur la vaccination d’un contexte de santé à un autre. Pour combler cette lacune, l’outil d’évaluation de la transférabilité de la COVID-19 au système d’information sur la vaccination de routine a été élaboré, éclairé par un examen documentaire, des consultations d’experts et des tests bêta. Cet outil s’articule autour de cinq domaines thématiques: contexte, fonctionnalité, technologie, utilisateurs et ressources. Chaque domaine thématique comprend des questions sur le système d’information sur la vaccination contre la COVID-19, l’état actuel et souhaité du système d’information sur la vaccination de routine et les écarts entre eux. Les scores de pertinence sont ensuite calculés pour évaluer si un système d’information sur la vaccination contre la COVID-19 convient à la vaccination de routine afin que les pouvoirs publics puissent tirer parti de ces investissements pour renforcer les programmes de vaccination de routine et l’écosystème de l’information sur la santé dans son ensemble. Resumen Para lograr la visión de la Agenda de Inmunización 2030 de un mundo donde todas las personas de todas partes se beneficien de las vacunas, es esencial invertir en sistemas de información sobre vacunación que puedan apoyar la identificación, el alcance y el monitoreo de niños con dosis cero y subvacunados. La rápida introducción de la vacuna COVID-19 condujo a la inversión en nuevos sistemas para recopilar, administrar y utilizar datos sobre vacunación. Si bien existen muchas herramientas digitales de evaluación de la salud, faltan instrumentos para ayudar a los responsables de la toma de decisiones a evaluar sistemáticamente la idoneidad de transferir un sistema de información sobre vacunación de un contexto sanitario a otro. Para corregir esta deficiencia, se creó el Marco de evaluación de la transferibilidad del sistema de información sobre la vacunación contra la COVID-19 a la vacunación sistemática (CRIISTA), sobre la base de la revisión de literatura, consultas a expertos y pruebas beta. El Marco está organizado en cinco áreas temáticas: contexto, funcionalidad, tecnología, usuarios y recursos. Cada área temática contiene preguntas referidas al sistema de información sobre la vacunación contra la COVID-19, el estado actual del sistema de información sobre la vacunación sistemática y su estado deseado, y las brechas entre ellos. Seguidamente, se calculan las puntuaciones de idoneidad para evaluar si un sistema de información sobre la vacunación contra la COVID-19 es adecuado para la vacunación sistemática, de modo que los Gobiernos puedan aprovechar estas inversiones para fortalecer los programas de vacunación sistemática y el sistema más amplio de información sanitaria.